文献速递流行病学与生物统计

个体 participant 数据 Meta 分析的方法学指导:一项系统综述

Methodological guidance for individual participant data meta-analyses: a systematic review.
PubMed 文献 · J Clin Epidemiol · 2025-11-25

该研究系统检索了九个主要电子数据库和灰色文献来源(截至2025年6月),最终纳入141项研究,旨在整合随机试验和观察性研究的个体 participant 数据 Meta 分析(IPD-MA)方法学指导。关键主题包括IPD-MA计划、数据获取与协调、分析策略及其他统计问题和报告。随机试验的IPD-MA指导较为充分,而观察性研究的推荐意见稀少;所有研究类型中63%被评为高质量。

要点

  • 该综述整合了141项研究,形成IPD-MA方法学指导的综合合成。
  • 随机试验的IPD-MA指导较为充分,观察性研究的推荐意见稀少。
  • 所有纳入研究中63%被评为高质量。

核心结论

  • 该综述将此前碎片化的指导整合为综合性合成,突出最佳实践和评价IPD-MA的关键领域。
  • 这些发现为Delphi共识过程制定专门的IPD-MA批判性评价工具提供了证据基础。

研究设计与样本

  • 系统综述,检索九个主要电子数据库和灰色文献来源(截至2025年6月),由两名评价员独立进行研究选择和数据提取。
  • 纳入报告实证、模拟、共识或叙述性研究并就IPD-MA方法学提供指导的文章,最终纳入141项研究。
  • 纳入研究中模拟研究占38%、实证研究占21%、方法学指导占12%。
  • 使用针对研究设计定制的工具评估质量,所有研究类型中63%被评为高质量。

主要发现

  • 关键主题包括IPD-MA计划、数据获取与协调、分析策略、其他统计问题以及报告。
  • 随机试验的IPD-MA指导较为充分,而观察性研究的推荐意见稀少。
  • 所有研究类型中63%被评为高质量。

关键数值与推荐

  • 纳入141项研究,其中模拟研究占38%、实证研究占21%、方法学指导占12%。
  • 所有研究类型中63%被评为高质量。

临床怎么用

  • 该综合为计划或审阅IPD-MA的团队提供了实用清单。
  • 该综合为共识-based评价工具奠定了基础,以帮助编辑、资助者和指南制定者判断质量并改进实践。

局限性

  • 观察性研究的推荐意见稀少。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To systematically identify and synthesize methodological guidance for conducting individual participant data meta-analyses (IPD-MAs) of randomized trials and observational studies, to inform the development of a critical appraisal tool for reports of IPD-MAs. STUDY DESIGN AND SETTING: We searched nine major electronic databases and gray literature sources through June 2025 using a strategy developed with a health sciences librarian. To be eligible, articles had to report empirical, simulation-based, consensus-based, or narrative research and offer guidance on the methodology of IPD-MA. Study selection and data extraction were performed independently by two reviewers. Quality was assessed using tools tailored to study design (eg, Aims, Data generating mechanism, Estimands, Methods, and Performance measures, Risk of Bias in Systematic Reviews, Appraisal of Guidelines for Research & Evaluation using Delphi, Scale for the Assessment of Narrative Review Articles). Extracted guidance was categorized thematically and mapped to appraisal domains. RESULTS: After screening 14,736 records, we included 141 studies. These encompassed simulation (38%), empirical (21%), and methodological guidance (12%), among others. Key themes included IPD-MA planning, data access and harmonization, analytical strategies, and other statistical issues, as well as reporting. While there was robust guidance for IPD-MA of randomized trials, recommendations for observational studies are sparse. Across all study types, 63% were rated high quality. CONCLUSION: This review synthesizes previously fragmented guidance into an integrative synthesis, highlighting best practices and critical domains for evaluating IPD-MAs. These findings formed the evidence base for a Delphi consensus process to develop a dedicated IPD-MA critical appraisal tool. PLAIN LANGUAGE SUMMARY: Meta-analyses often pool published summaries from many studies. That approach can miss important details and introduce bias. An IPD-MA instead reanalyses the original, participant-level data across studies. IPD-MAs are powerful but complex, and practical guidance is scattered, especially for observational studies. We wanted to bring these recommendations together in one place and identify candidate items for a tool to assess the quality of a completed IPD-MA. We systematically searched eight databases from their inception to 2025 to identify papers offering practical guidance on conducting IPD-MAs for health interventions. We organized guidance across the full project life cycle, from planning, finding and accessing data, to preparing and checking data, analyzing results, and reporting. We highlighted where experts broadly agree and where gaps remain. We found 141 relevant papers published between 1995 and 2025. Among these, we identified 25 key topic areas and several smaller subtopics. Many papers covered more than one topic, so we allowed them to appear in multiple categories rather than forcing a single classification. From this mapping, we developed a clear set of recommendations organized around four themes: IPDMA planning; identification and access to studies and individual participant data; methods for meta-analysis; and other special considerations, such as methods for observational studies. We also identified notable gaps for observational IPD-MAs. Our synthesis offers a practical checklist for teams planning or reviewing IPD-MAs. It also lays the groundwork for a consensus-based appraisal tool to help editors, funders, and guideline developers judge quality and improve practice.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Otalike EG, Clarke M, Akhter F, et al. Methodological guidance for individual participant data meta-analyses: a systematic review. J Clin Epidemiol. 2025. PMID: 41309007. doi:10.1016/j.jclinepi.2025.112089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。